Biotechnology VALUE FUND II L.P., 10% Owner at INFINITY PHARMACEUTICALS, INC. (INFI), bought 350,000 shares at $1.20 ($420K) on 2018-12-13, disclosed to the SEC on 2018-12-17.
Open-market purchase of $420k INFI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 54,461 | $65K | 15.6% |
| 2 | $1.20 | 54,461 | $65K | 15.6% |
| 3 | $1.20 | 120,539 | $145K | 34.4% |
| 4 | $1.20 | 120,539 | $145K | 34.4% |
| Total | $1.20 avg | 350,000 | $420K | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |